drugset / Trial / NCT01176760

Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects

NCT01176760

Non-randomizedParallel-groupOpen-labelBasic science

Summary

The aim of this study is to investigate the role of transmission via the vagal nerve for the effect of glucose and Glucagon-like peptide-1 (GLP-1) in respect to insulin secretion. The hypothesis is that a great deal of the effects of GLP-1 is mediated via the nervous system and for this reason the investigators will research individuals with and without intact nervous supply.

Timeline

Start
2009-08
Primary completion
2011-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Vildagliptin Other / unclassified 50 mg

Indications

No indication recorded.